{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Tiotropium Bromide is a prescription medication available as an inhalation powder in capsules, manufactured by Lupin Pharmaceuticals, Inc. It acts as an anticholinergic bronchodilator to help open airways in conditions like chronic obstructive pulmonary disease (COPD). Each capsule contains 18 micrograms of tiotropium bromide monohydrate for oral inhalation. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Tiotropium bromide \u2014 ANDA 207070 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207070", "mediaType": "text/html", "title": "Tiotropium bromide"}], "identifier": "ANDA207070", "issued": "2016-09-16", "keyword": ["pharmaceuticals", "medications", "public-health", "drug", "fda"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Tiotropium bromide"}